英文摘要 |
Malignant hypercalcemia is a common and critical problem for Oncology patients. The impact of the hypercalcemia and its acute onset can belief threatening. A hypercalcemia prevention program, which included 18 slides, was developed according to the Health Belief Model. The education program was provided via either group or individual teaching in a Hematology unit. The education program was conducted by one group, pre-and post-test, pre-experimental study from May 1998 to July 1998. Twenty-nine hospitalized patients were enrolled in the study. The education program was evaluated using hypercalcemia knowledge questionnaire, hypercalcemia prevention activities checklist, and hypercalcemia sign and symptoms checklist. The pre-test for hypercalcemia knowledge was conducted before the health education, with the post-test conducted 4 days later or before the discharge. Prevention activities, serum calcium level, and hypercalcemia symptoms were evaluated before the education program and followed-up monthly for 3 months. The result showed that the mean score for the hypercalcemia knowledge changed significantly from 6.3±4.6 before the education to 13.6±3.1 after the education according to the Wilcoxon signed Rank Test (p<0.05). Within the 3-month following-up, seven patients died of sepsis and renal failure while other 22 patients' daily living activities were getting worse significantly via Wilcoxon signed Rank Test (p<0.05). Preventing activities, which included taking adequate fluid, avoiding high calcium diet, and corrected positioning changed significantly via Wilcoxon Signed Rank Test (p<0.05). The study showed marked progresses in understanding hypercalcemia and taking the prevention behaviors after this education program. No hypercalemia was found for all 22 subjects within the 3-month follow-up. No conclusion can be made about the relation between the prevention education and hypercalcemia because of the limited study design. In General, the study suggests emphasizing and extending the hypercalcemia prevention program not only for Hematology patients but also for all Oncology patients. |